KR20120019968A - The method of extracting food component which have an antithrombotic effect from ficus carica linnoeus and the antithrombotic extract - Google Patents

The method of extracting food component which have an antithrombotic effect from ficus carica linnoeus and the antithrombotic extract Download PDF

Info

Publication number
KR20120019968A
KR20120019968A KR1020100083618A KR20100083618A KR20120019968A KR 20120019968 A KR20120019968 A KR 20120019968A KR 1020100083618 A KR1020100083618 A KR 1020100083618A KR 20100083618 A KR20100083618 A KR 20100083618A KR 20120019968 A KR20120019968 A KR 20120019968A
Authority
KR
South Korea
Prior art keywords
extract
antithrombotic
ethanol
extracting
extraction
Prior art date
Application number
KR1020100083618A
Other languages
Korean (ko)
Other versions
KR101144433B1 (en
Inventor
박금주
강정일
김태석
여익현
남승우
Original Assignee
(주)풀무원홀딩스
풀무원건강생활 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)풀무원홀딩스, 풀무원건강생활 주식회사 filed Critical (주)풀무원홀딩스
Priority to KR1020100083618A priority Critical patent/KR101144433B1/en
Publication of KR20120019968A publication Critical patent/KR20120019968A/en
Application granted granted Critical
Publication of KR101144433B1 publication Critical patent/KR101144433B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L19/00Products from fruits or vegetables; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/326Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/14Extraction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PURPOSE: An extracting method of food components having antithrombotic function from figs, and an antithrombotic extract are provided to prevent the generation of side effects from the food components. CONSTITUTION: An extracting method of food components having antithrombotic function from figs comprises the following steps: cutting the figs, and extracting water-soluble components from the figs using water at the temperature lower than 30 deg C; removing insoluble components from the obtained extract by centrifugal separating; inserting ethanol into the extract; and settling the mixture for 12 hours at 4 deg C for removing ethanol soluble components.

Description

무화과로부터 항혈전 기능의 식품성분를 추출하는 방법 및 항혈전성 추출물{The method of extracting food component which have an antithrombotic effect from Ficus Carica Linnoeus and the antithrombotic extract}The method of extracting food component which have an antithrombotic effect from Ficus Carica Linnoeus and the antithrombotic extract}

본 발명은 무화과로부터 항혈전 기능의 식품성분을 추출하는 방법 및 그 항혈전성 추출물에 관한 것으로, 보다 상세하게는 무화과로부터 콜라겐과 같은 응집유도체의 자극에 의해 활성화되어 응집반응을 일으키는 혈소판에 대하여 항응고작용을 나타내는 항혈전 기능의 추출물를 추출하는 방법 및 그 방법에 의하여 추출된 항혈전성 추출물에 관한 것이다.The present invention relates to a method for extracting anti-thrombotic food components from figs and an antithrombotic extract thereof, and more particularly, to anti-platelets that are activated by stimulation of agglutinant derivatives such as collagen from figs to cause agglutination. The present invention relates to a method for extracting an antithrombotic extract that exhibits a coagulation action and an antithrombogenic extract extracted by the method.

혈소판은 혈관 파손시에 혈액 응고인자들에 의한 응고 과정을 촉진시킴으로 혈관 파손 부위로 부터의 급격한 혈액의 손실을 방지하는 생체 방어기전이다. 그러나 폐쇄 혈관내에서의 혈소판 활성화에 의한 혈소판의 점착, 응집, 방출반응은 혈전형성을 초래하게 되고 이는 각종 혈전성 질환을 유발 시키게 됨으로 동맥경화증, 고혈압, 당뇨병 등의 성인병 발현에도 관여하게 되는 것이다. 따라서 이러한 혈소판응집 억제작용을 갖는 항혈소판 물질들은 혈전증상의 재발방지 및 다양한 혈전관련 질환의 치료 및 예방에 그 응용 가치가 크다고 하겠다.Platelets are a biological defense mechanism that prevents the rapid loss of blood from the site of blood vessel breakage by promoting the coagulation process by blood clotting factors during blood vessel breakage. However, adhesion, aggregation, and release of platelets by platelet activation in closed blood vessels result in thrombosis, which causes various thrombotic diseases and thus is involved in the expression of adult diseases such as atherosclerosis, hypertension, and diabetes. Therefore, these antiplatelet substances having platelet aggregation inhibitory action have great application value in preventing recurrence of thrombosis and treatment and prevention of various thrombosis related diseases.

혈전성 질환의 예방과 치료를 위하여 현재 사용되어지고 있는 약물로는 아스피린(aspirin)과 헤파린(heparin), 쿠마린(coumarin)등이 있으나 이들은 혈전에 관한 특이성이 없고 장기간 사용시에는 체내에서 출혈을 일으키는 등의 부작용이 있어 이에 따른 새로운 항혈소판제의 개발이 요구되어지고 있는 실정이다.Drugs currently being used for the prevention and treatment of thrombotic diseases include aspirin, heparin, and coumarin, but they are not specific for blood clots and cause bleeding in the body over long periods of time. There is a side effect of the development of a new antiplatelet agent is required accordingly.

이와 관련하여 연구자들은 다양한 천연물로부터의 항혈전 활성을 보고하고 있는데 무화과에서부터 분리한 에탄올 추출물로부터 이러한 활성이 보고되어지기도 하였다.(Anwarul HG et.al., Journal of Ethnopharmacology 119 (2008) 1-5)In this regard, researchers report antithrombotic activity from a variety of natural products, some of which have been reported from ethanol extracts isolated from figs (Anwarul HG et.al., Journal of Ethnopharmacology 119 (2008) 1-5).

그러나, 천연물로부터의 얻게되는 유효성분들은 추출 방법등에 따라 추출되는 성분들의 종류가 차이가 나게되고 기대되는 효과도 달라질 수 있다.However, the active ingredients obtained from natural products are different depending on the extraction method, the type of components to be extracted and the expected effect may also vary.

에 본 발명자들은 우수한 항혈전성 효과를 가지는 무화과의 추출방법에 대해 연구하였고 본 발명을 완성하였다. 본 발명은 무화과로부터 항혈전성 효과가 우수하면서도 부작용을 일으키지 않는 유효성분을 추출하는 방법 및 그 추출법에 의해 추출된 항혈전성 추출물을 제공하는 것을 목적으로 한다.The present inventors studied a method of extracting figs having an excellent antithrombogenic effect and completed the present invention. An object of the present invention is to provide a method for extracting an active ingredient having excellent antithrombogenic effect from figs and not causing side effects, and an antithrombogenic extract extracted by the extracting method.

상기 목적을 달성하기 위한 본 발병은 무화과를 절단하고 추출용매로 물을 사용하여 30℃이하에서 수용성 성분들을 추출하는 단계(P1), 추출용액을 원심분리하여 불용성 성분을 제거하는 단계(P2), 에탄올의 농도가 75%이상이 되도록 에탄올을 넣고 4℃에서 12시간 동안 정치시켜 에탄올 용해성 성분을 제거하는 단계(P3)를 포함하는 무화과로부터 항혈전성 성분을 추출하는 방법 및 항혈전효과가 우수한 무화과의 항혈전성 추출물에 관한 것이다.The present invention for achieving the above object is the step of cutting the fig and extracting the water-soluble components below 30 ℃ using water as the extraction solvent (P1), the step of centrifuging the extraction solution to remove the insoluble components (P2), Method of extracting anti-thrombotic components from figs including step (P3) of adding ethanol so that the concentration of ethanol is at least 75% and standing at 4 ° C. for 12 hours to remove ethanol-soluble components and figs having excellent antithrombotic effect It relates to an antithrombotic extract.

이하 본 발명을 상세히 설명하고자 한다.Hereinafter, the present invention will be described in detail.

건조시키거나 건조시키지 않은 무화과를 분쇄 혹은 절단한 뒤 추출용매를 사용하여 추출한다. 이때 추출용매로는 산, 염기 또는 물을 모두 사용할 수 있으나, 식품 원료로써의 안전성을 고려하여 물을 사용하여 추출하는 것이 바람직하겠다. 추출시 물의 온도는 30℃(최대 50℃)를 넘기지 않도록 하여 비교적 저온에서 추출하여야 한다.Fig dried or undried figs are crushed or cut and extracted using an extraction solvent. At this time, the acid, base or water can be used as the extraction solvent, but it is preferable to extract using water in consideration of safety as a food raw material. During extraction, the water temperature should be extracted at a relatively low temperature so that it does not exceed 30 ℃ (max 50 ℃).

추출이 완료되면 추출액은 원심분리기를 사용하여 침전시켜 상등액을 분리하고 이를 여과한다. 이후 여과된 추출액에 에탄올을 넣는다. 이때 에탄올의 최종농도가 75% 이상이 되도록 조절하여 넣고 12시간 동안 10℃에서 정치시킨 후 에탄올에 용해된 에탄올 용해성 성분을 분리하여 제거함으로 항혈전 효과가 우수한 무화과의 항혈전성 추출물을 제조 할 수 있다. 항혈전성 추출물은 그대로 사용하거나 필요에 따라 건조시켜 사용할 수 있다. 건조는 동결건조 등의 방법을 이용하며 건조 온도가 50℃가 넘지 않도록 하여야 한다. 상기 무화과의 항혈전성 추출물은 in vitro 실험에서 우수한 항혈전 효과를 나타낸다. 상기 추출물에 대하여 임피던스법(Impedence method)을 이용한 항혈소판 응집능을 측정한 결과 매우 우수한 항혈전효과를 나타내었다.After the extraction is completed, the extract is precipitated using a centrifuge to separate the supernatant and filter it. Then ethanol is added to the filtered extract. At this time, the final concentration of ethanol is adjusted to be 75% or more, and the mixture is allowed to stand at 12 ° C. for 12 hours, and then the ethanol soluble components dissolved in ethanol are separated and removed to prepare an antithrombotic extract of figs having excellent antithrombotic effect. have. The antithrombotic extract can be used as it is or dried as necessary. Drying should be done by lyophilization method and drying temperature should not exceed 50 ℃. The antithrombotic extract of figs shows excellent antithrombotic effect in in vitro experiments. As a result of measuring the antiplatelet aggregation ability using the impedance method (Impedence method) for the extract showed a very good antithrombotic effect.

본 발명의 추출 방법에 의해 무화과로부터 항혈소판 응집능이 탁월한 물질을 추출할 수 있다. 그 추출물은 콜라겐(collagen)과 같은 응집유도체의 자극에 의해 응집반응을 일으키는 혈소판의 활성화를 방지함으로 이에따른 혈액응고체계의 가속화를 막아 궁극적으로 혈전의 생성을 억제할 수 있는 것이다. 따라서 이는 뇌출혈, 심근경색, 동맥경화 등의 심혈관계 질환의 예방에 이용 될 수 있으며, 또한 무화과는 식품임으로 부작용이 없다는 장점이 있다.By the extraction method of the present invention, it is possible to extract substances excellent in antiplatelet aggregation ability from figs. The extract prevents the activation of platelets causing the aggregation reaction by stimulation of agglutinating derivatives such as collagen, thereby preventing the acceleration of the blood coagulation system and ultimately inhibiting the generation of blood clots. Therefore, it can be used for the prevention of cardiovascular diseases such as cerebral hemorrhage, myocardial infarction, arteriosclerosis, etc. Also, since figs are foods, there are no side effects.

도 1. 저온 추출을 특징으로하는 무화과로부터 항혈전성 추출물 제조 공정 모식도Figure 1. Schematic diagram of a process for producing antithrombogenic extract from figs characterized by low temperature extraction

이하 본발명을 실시예를 통해 보다 상세하게 설명하고자 한다.Hereinafter, the present invention will be described in more detail with reference to Examples.

실시예 1)Example 1

추출시 용매의 추출온도에 따른 추출물의 항응고활성을 비교하기 위하여 무화과를 절단하고 이를 각각 10℃, 30℃, 50℃, 70℃, 100℃의 온도로 추출한 후 여과하고 에탄올을 첨가하여 에탄올 용해성 물질을 제거한 뒤 임피던스법을 이용한 항혈소판 응집능을 측정하였다.In order to compare the anticoagulant activity of the extract according to the extraction temperature of the solvent during the extraction, the figs were cut and extracted at temperatures of 10 ° C., 30 ° C., 50 ° C., 70 ° C. and 100 ° C., respectively, filtered and ethanol was dissolved by adding ethanol. After removing the material, the antiplatelet aggregation ability was measured by the impedance method.

임피던스법은 혈액내로 전류를 통과시켜 혈소판 응집에 따른 전기적 저항의 변화를 측정하는 방법으로 전혈(Whole blood)에서의 측정이 가능한 방법이다.Impedance method is a method of measuring the change in electrical resistance according to platelet aggregation by passing a current through the blood is a method that can be measured in whole blood.

실험을 위하여 6주령의 SD(Sprague-Dewley)rat으로부터 채혈하여 0.38% 구연산나트륨(sodium citrate)을 혈액에 대하여 1:9(v/v)의 비율이 되도록 한 전혈(Whole blood)을 사용하였다.Whole blood was used for the experiment to collect 0.38% sodium citrate at a ratio of 1: 9 (v / v) to blood by collecting blood from 6 week old Sprague-Dewley rats.

상기의 추출방법에 따른 무화과의 온도별 추출물을 5mg/mL의 농도로 희석하여 각각을 전혈에 처리한 후 콜라겐에 의한 응집유도 후 각각의 저항값을 측정하고 이를 아래 수학식에 따라 항혈소판활성을 계산하였다. 계산한 항혈소판활성은 표1에 나타내었다.After diluting the extract by the temperature of the fig according to the above extraction method to a concentration of 5mg / mL, each was treated with whole blood and measured the resistance values after the coagulation induction by collagen. Calculated. The calculated antiplatelet activity is shown in Table 1.

수학식 항혈소판활성(%) =Equation (%) = antiplatelet activity

Figure pat00001
Figure pat00001

표1Table 1

Figure pat00002
Figure pat00002

상기 표1의 결과에서 추출온도가 증가할수록 항혈소판활성이 감소함을 알 수 있었다.In the results of Table 1, the antiplatelet activity was decreased as the extraction temperature was increased.

실시예 2)Example 2

본 발명의 추출 방법에 의해 제조된 무화과 추출물에 대한 항혈소판능을 기존에 보고된바 있는 무화과 에탄올 추출물과 활성을 비교함으로 본 발명에 의한 무화과 추출물의 우수성을 확인하였다. 무화과 에탄올 추출물의 제조는 기존 보고자료에 기술한 방법을 충실히 따라 제조하였다. 항혈소판능의 활성은 실시예 1에서 기술한 실험법을 따라 측정하였다.The antiplatelet activity of the fig extract prepared by the extraction method of the present invention was confirmed by comparing the activity of the fig ethanol extract with the previously reported fig ethanol extract of the present invention. The preparation of the fig ethanol extract was made faithfully following the method described in the previous report. The activity of antiplatelet activity was measured according to the experimental method described in Example 1.

표2Table 2

Figure pat00003
Figure pat00003

상기표2의 결과에서 본 발병 무화과 추출물에서 뛰어난 항혈소판활성을 또한 확인 할 수 있었다. 다만 항혈소판 활성이 있다고 보고된 기존보고 무화과 추출물의 경우, 항혈소판활성을 나타내지 않았다. 이는 본 실시예에서 사용된 실험법의 차이에 기인된 것으로 판단된다. 기존 보고에서는 항혈소판 활성 확인을 위하여 PRP(Platelet Rich Plasma)를 사용하고 혈소판 응집 inducer로써 ADP와 Adrenaline을 사용한 반면 본 실시예에서는 전혈내 혈소판만을 이용하였고 혈소판 응집 inducer는 collagen을 사용하였다.From the results of Table 2, it was also confirmed excellent antiplatelet activity in the pathogenic fig extract. However, in the case of the previously reported fig extract reported to have antiplatelet activity, it did not show antiplatelet activity. This is believed to be due to the difference in the experimental method used in this example. In the previous report, platelet rich plasma (PRP) was used to identify antiplatelet activity and ADP and Adrenaline were used as platelet aggregation inducers. In this example, only whole blood platelets were used and platelet aggregation inducer was used as collagen.

실시예 3)Example 3

항혈전 활성을 나타내는 무화과 추출물의 성분을 확인하기위하여 추출물 내 영양성분과 총다당체함량 분석하였다. 영양성분 중 지방은 Soxhlet extract 법을, 단백질은 kjedahl method를 이용하였고 수분과 회분은 상압가열건조법으로 측정하였다. 탄수화물의 함량은 이들의 값으로부터 다음의 계산식에 적용하여 함량을 확인하였으며 총다당체의 함량은 페놀과 황산을 이용한 발색법으로 측정하였다.To determine the components of the fig extract showing antithrombotic activity, the nutritional components and total polysaccharide content of the extract were analyzed. Fat was measured by Soxhlet extract method, protein was kjedahl method, and moisture and ash were measured by atmospheric heating. Carbohydrate content was determined from these values by applying the following formula and the total polysaccharide content was measured by color development using phenol and sulfuric acid.

탄수화물 함량 계산식 = 100-(조지방+조단백질+수분+회분)Carbohydrate Content Formula = 100- (Crude Fat + Crude Protein + Moisture + Ash)

표3Table 3

Figure pat00004
Figure pat00004

표4Table 4

Figure pat00005
Figure pat00005

분석결과, 상기표3에서 본발명 무화과 추출물의 영양성분은 탄수화물 67.51%, 조단백질 12.52%, 조지방 0.11% 및 탄수화물 중 총다당체의 함량이 10.35%로 나타난 반면, 기존 보고 무화과 에탄올 추출물은 탄수화물 65.52%, 조단백질 6.57%, 조지방 0.73% 및 탄수화물 중 총다당체의 함량이 0.94%으로(표 4) 두 추출물간 성분조성에 큰 차이를 확인 할 수 있었고 이는 두 추출물이 상이한 물질임을 나타낸다.As a result of the analysis, the nutrient composition of the present invention fig extract is carbohydrate 67.51%, crude protein 12.52%, crude fat 0.11% and carbohydrate content of 10.35%, whereas the previously reported fig ethanol extract carbohydrate 65.52%, 6.57% of crude protein, 0.73% of crude fat and 0.94% of total polysaccharide in carbohydrates (Table 4) showed a big difference in the composition of the two extracts, indicating that the two extracts are different substances.

Claims (5)

무화과를 절단하고 추출용매로 물을 사용하여 30℃이하에서 수용성 성분들을 추출하는 단계(P1), 추출용액을 원심분리하여 불용성 성분을 제거하는 단계(P2), 에탄올의 농도가 75%이상이 되도록 에탄올을 넣고 4℃에서 12시간 동안 정치시켜 에탄올 용해성 성분을 제거하는 단계(P3)를 포함하는 무화과로부터 항혈전성 성분을 추출하는 방법Cutting the fig and extracting the water-soluble components below 30 ℃ using water as the extraction solvent (P1), centrifuging the extraction solution to remove the insoluble components (P2), so that the concentration of ethanol more than 75% Method of extracting the antithrombogenic component from the fig including the step (P3) of adding ethanol and standing at 4 ° C. for 12 hours to remove the ethanol soluble component. 제 1항에 있어서 추출온도를 30℃이하로 하여 저온 추출을 하는 것을 특징으로하는 무화과로부터 항혈전성 성분을 추출하는 방법.The method for extracting anti-thrombotic component from figs according to claim 1, wherein the extract is subjected to low temperature extraction at an extraction temperature of 30 deg. 제 1항에 있어서, 에탄올 용해성 물질을 제거한는 단계(P3)에서 12시간 동안 10℃ 이하에서 정치한 후 에탄올 불용성 물질을 획득하는 단계를 포함하는 것을 특징으로 하는 무화과로부터 항혈전성 성분을 추출하는 방법.The method of extracting an antithrombogenic component from a fig, according to claim 1, wherein the step of removing the ethanol soluble substance comprises obtaining the ethanol insoluble substance after standing at 10 DEG C or lower for 12 hours in the step (P3). . 제1항 내지 제3항 중 어느 한 항의 추출 방법에 의해 추출된 식품소재로 활용 가능한 항혈전성 추출물Anti-thrombotic extract that can be used as a food material extracted by the extraction method of any one of claims 1 to 3. 제 4항의 추출물을 유효성분으로 포함하는 항혈전성 건강기능식품.Antithrombotic health functional food comprising the extract of claim 4 as an active ingredient.
KR1020100083618A 2010-08-27 2010-08-27 The method of extracting food component which have an antithrombotic effect from Ficus Carica Linnoeus and the antithrombotic extract KR101144433B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100083618A KR101144433B1 (en) 2010-08-27 2010-08-27 The method of extracting food component which have an antithrombotic effect from Ficus Carica Linnoeus and the antithrombotic extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100083618A KR101144433B1 (en) 2010-08-27 2010-08-27 The method of extracting food component which have an antithrombotic effect from Ficus Carica Linnoeus and the antithrombotic extract

Publications (2)

Publication Number Publication Date
KR20120019968A true KR20120019968A (en) 2012-03-07
KR101144433B1 KR101144433B1 (en) 2012-05-15

Family

ID=46128753

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100083618A KR101144433B1 (en) 2010-08-27 2010-08-27 The method of extracting food component which have an antithrombotic effect from Ficus Carica Linnoeus and the antithrombotic extract

Country Status (1)

Country Link
KR (1) KR101144433B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103704796A (en) * 2014-01-14 2014-04-09 广西南宁桂景大酒店有限责任公司 Spiral seaweed and maca soup and production method thereof
CN105211847A (en) * 2015-10-23 2016-01-06 苏春培 The preparation method of Hericium erinaceus conidia powder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100685110B1 (en) * 1999-04-24 2007-02-22 (유)키토산메디신테크 The manufacturing process of Can drink beverage by use of activated Figue material
KR100966838B1 (en) * 2007-12-28 2010-06-29 재단법인 대구테크노파크 A beverage using fig and a preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103704796A (en) * 2014-01-14 2014-04-09 广西南宁桂景大酒店有限责任公司 Spiral seaweed and maca soup and production method thereof
CN105211847A (en) * 2015-10-23 2016-01-06 苏春培 The preparation method of Hericium erinaceus conidia powder

Also Published As

Publication number Publication date
KR101144433B1 (en) 2012-05-15

Similar Documents

Publication Publication Date Title
CA3018219C (en) Corn protein concentrate and methods of manufacturing same
JP2015515493A5 (en)
JP7011060B2 (en) Fibrous structure derived from potato protein and foodstuffs containing it
Sabbione et al. Antithrombotic effects of Amaranthus hypochondriacus proteins in rats
KR101144433B1 (en) The method of extracting food component which have an antithrombotic effect from Ficus Carica Linnoeus and the antithrombotic extract
KR101645855B1 (en) Pharmaceutical composition comprising the extract of lepiduium meyenii hypocotyl as an effective component for prevention or treatment of thrombosis and health functional food comprising the same
CN104558115A (en) Antioxidant polypeptide with Raja porosa meat protein as well as preparation method and application of antioxidant polypeptide
KR101378527B1 (en) Composition comprising the extract of Cedrela sonensis A. Juss for prevention or control of thrombosis
Ryu et al. Beneficial effect of persimmon leaves and bioactive compounds on thrombosis
KR100704003B1 (en) A compound comprising 2?-hydroxy-oleanolic acid for prevention and control of thrombosis
KR101361148B1 (en) Pharmaceutical and Food composition comprising juice of white radish Raphanus sativus L. for prevention or control of thrombosis
KR102084503B1 (en) Pharmaceutical composition comprising the zingiber officinale leaf extracts as an effective component for prevention or treatment of thrombosis and health functional food comprising the same
KR101338190B1 (en) Pharmaceutical and Food composition comprising the antioxidant juice of bordeaux radish Raphanus sativus L. for prevention or control of thrombosis
KR102117896B1 (en) Composition comprising Extract of Crataegus pinnatifida Bunge for Antithrombosis
RU2421024C1 (en) Method for complex processing of dandelion roots
KR101645878B1 (en) Pharmaceutical composition comprising the organic solvent fractions of platycodon grandiflorum as an effective component for prevention or treatment of thrombosis and health functional food comprising the same
JP2006028074A (en) Blood platelet coagulation inhibitory composition
KR100345983B1 (en) Syzygium Aromaticum Extract Having Anti-coagulation Effect and its Refining Method
KR20150104868A (en) Pharmaceutical composition for prevention or treatment of thrombosis comprising the seed extract of cornus officinalis
KR20140109099A (en) A pharmaceutical composition comprising the hexane fraction of gardenia jasminoides extract as an effective component for anti-platelet aggregation and a health functional food comprising the same
KR102216218B1 (en) Pharmaceutical composition comprising ethanol extracts of seedpod of nelumbo nucifera as an effective component for prevention or treatment of thrombosis and health functional food comprising the same
KR101125718B1 (en) Food additive composition comprising of cherry extracts against blood clots by inhibiting thrombin activity
US2284566A (en) Products capable of preventing the coagulation of blood and a method of making the same
KR20190066491A (en) Pharmaceutical composition comprising the extracts from the flesh and seed of passion fruit as an effective component for prevention or treatment of thrombosis and health functional food comprising the same
KR102120490B1 (en) Pharmaceutical composition for prevention or treatment of thrombosis comprising the ethylacetate fraction of shiitake mushroom extract as an effective component and health functional food comprising the same

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20160411

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20170425

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20180410

Year of fee payment: 7

FPAY Annual fee payment

Payment date: 20190416

Year of fee payment: 8